Fig. 10From: Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinomaThe mutation profile and TMB among low-risk and high-risk groups. a Mutation profile in the high-risk group. b Mutation profile in the low-risk group. c The relationship between the immune-related risk signature and TMB. d The association of TMB and overall survival in the TCGA HCC datasetBack to article page